Overview
- Clinicians in Mexico, Peru and Spain call for routine prostate checks starting at age 45, or at 40 for men with a first‑degree family history.
- Specialists report cure rates above 95% when detected early, while seven in ten cases are still found late and Mexico records roughly 25,000–26,000 new diagnoses and about 7,000–7,500 deaths each year.
- Recommended screening relies on a PSA blood test complemented by a digital rectal exam conducted yearly, with doctors addressing stigma and emphasizing that evaluations are quick and low‑discomfort.
- Treatment has shifted toward minimally invasive robotic surgery and individualized pathways, including active surveillance for very low‑risk tumors to preserve urinary and sexual function.
- New developments reported this week include a Cleveland Clinic study testing AI to interpret prostate MRIs and Cofepris approval of Talazoparib in Mexico, while a 45‑year‑old patient’s remission story highlights the value of prompt evaluation.